Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Rigel Pharmaceuticals - 25 Year Stock Price History | RIGL

Historical daily share price chart and data for Rigel Pharmaceuticals since 2000 adjusted for splits and dividends. The latest closing stock price for Rigel Pharmaceuticals as of April 04, 2025 is 17.24.
  • The all-time high Rigel Pharmaceuticals stock closing price was 1068.75 on January 03, 2001.
  • The Rigel Pharmaceuticals 52-week high stock price is 29.82, which is 73% above the current share price.
  • The Rigel Pharmaceuticals 52-week low stock price is 7.48, which is 56.6% below the current share price.
  • The average Rigel Pharmaceuticals stock price for the last 52 weeks is 15.46.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Rigel Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 20.1184 17.3200 24.3900 16.2500 17.2400 2.50%
2024 13.7357 14.6000 27.8800 7.7300 16.8200 16.00%
2023 12.9002 13.4000 20.0000 7.2240 14.5000 -3.33%
2022 17.3978 27.4000 34.5000 6.7030 15.0000 -43.40%
2021 36.6833 34.7000 49.3000 23.6000 26.5000 -24.29%
2020 23.2289 20.2000 41.2500 12.7000 35.0000 63.55%
2019 21.6518 23.6000 26.5000 16.0000 21.4000 -6.96%
2018 33.4187 39.6000 45.4000 20.8000 23.0000 -40.72%
2017 28.8211 24.9000 43.0000 19.6000 38.8000 63.03%
2016 26.7270 28.6000 40.1000 19.4000 23.8000 -21.45%
2015 31.4659 23.9000 48.7500 20.6000 30.3000 33.48%
2014 29.4388 29.9000 47.5000 16.8000 22.7000 -20.35%
2013 44.4617 67.0000 75.7000 23.5000 28.5000 -56.15%
2012 88.4648 81.9000 112.0000 55.1000 65.0000 -17.62%
2011 77.1054 77.0000 101.5000 65.4000 78.9000 4.78%
2010 80.2703 94.9000 98.3000 63.7000 75.3000 -20.82%
2009 80.6317 78.4000 146.1000 43.3000 95.1000 18.88%
2008 193.6285 246.9000 281.9000 53.8000 80.0000 -68.49%
2007 105.4869 118.9000 274.3000 66.7000 253.9000 113.90%
2006 100.2584 84.6000 121.9000 72.4000 118.7000 41.99%
2005 189.4513 234.4000 245.6000 76.2000 83.6000 -65.77%
2004 209.9108 199.1000 287.2000 111.5000 244.2000 27.19%
2003 104.0465 105.3000 192.0000 52.2000 192.0000 93.76%
2002 259.3768 407.7000 459.0000 94.5900 99.0900 -76.32%
2001 549.0107 1023.7500 1068.7500 292.5000 418.5000 -53.50%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.321B $0.179B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $74.838B 29.53
Zoetis (ZTS) United States $73.729B 27.81
Takeda Pharmaceutical (TAK) Japan $47.315B 10.47
Daiichi Sankyo, - (DSNKY) Japan $45.571B 27.77
Sandoz Group AG (SDZNY) Switzerland $18.445B 0.00
Merck (MKKGY) Germany $17.719B 14.66
Astellas Pharma (ALPMY) Japan $17.481B 12.39
Summit Therapeutics (SMMT) United States $14.230B 0.00
United Therapeutics (UTHR) United States $13.845B 12.53
Shionogi (SGIOY) Japan $12.760B 12.78
Corcept Therapeutics (CORT) United States $12.051B 92.11
Neurocrine Biosciences (NBIX) United States $11.027B 33.62
IPSEN (IPSEY) France $9.797B 0.00
Orion OYJ (ORINY) Finland $8.460B 23.98
Madrigal Pharmaceuticals (MDGL) United States $7.314B 0.00
Stevanato Group S.p.A (STVN) Italy $6.184B 39.27
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.254B 10.76
Grifols, S.A (GRFS) Spain $4.889B 0.00
Ionis Pharmaceuticals (IONS) United States $4.796B 0.00
Soleno Therapeutics (SLNO) United States $3.277B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.121B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.945B 12.01
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.598B 16.11
NewAmsterdam Pharma (NAMS) Netherlands $2.248B 0.00
Hypermarcas (HYPMY) Brazil $2.131B 8.41
Recursion Pharmaceuticals (RXRX) United States $2.127B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.915B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.567B 0.00
Guardian Pharmacy Services (GRDN) United States $1.346B 0.00
Indivior (INDV) United States $1.314B 5.71
ARS Pharmaceuticals (SPRY) United States $1.234B 157.25
Evotec AG (EVO) Germany $1.184B 0.00
Dyne Therapeutics (DYN) United States $1.183B 0.00
Ardelyx (ARDX) United States $1.170B 0.00
Ocular Therapeutix (OCUL) United States $1.166B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.104B 44.67
Enliven Therapeutics (ELVN) United States $0.964B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.09
Harrow (HROW) United States $0.948B 0.00
Xeris Biopharma Holdings (XERS) United States $0.845B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.757B 0.00
Bioventus (BVS) United States $0.750B 19.47
Xencor (XNCR) United States $0.750B 0.00
Cronos Group (CRON) Canada $0.692B 0.00
KalVista Pharmaceuticals (KALV) United States $0.574B 0.00
Organogenesis (ORGO) United States $0.548B 0.00
USANA Health Sciences (USNA) United States $0.510B 10.37
Savara (SVRA) United States $0.478B 0.00
Elite Pharmaceuticals (ELTP) United States $0.465B 0.00
Akebia Therapeutics (AKBA) United States $0.454B 0.00
Relay Therapeutics (RLAY) United States $0.444B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.442B 0.00
Verve Therapeutics (VERV) United States $0.406B 0.00
Zevra Therapeutics (ZVRA) United States $0.405B 0.00
Siga Technologies (SIGA) United States $0.391B 6.68
Tourmaline Bio (TRML) United States $0.391B 0.00
Altimmune (ALT) United States $0.385B 0.00
Oruka Therapeutics (ORKA) United States $0.384B 0.00
Aldeyra Therapeutics (ALDX) United States $0.343B 0.00
Heron Therapeutics (HRTX) United States $0.335B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.314B 0.00
OmniAb (OABI) United States $0.293B 0.00
Aquestive Therapeutics (AQST) United States $0.287B 0.00
Esperion Therapeutics (ESPR) United States $0.285B 36.00
CytoDyn (CYDY) United States $0.283B 0.00
ProKidney (PROK) United States $0.256B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.235B 73.50
Nature's Sunshine Products (NATR) United States $0.232B 27.28
Wellgistics Health (WGRX) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.213B 0.00
Profound Medical (PROF) Canada $0.175B 0.00
Nanobiotix S.A (NBTX) France $0.169B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
Korro Bio (KRRO) United States $0.163B 0.00
Inhibikase Therapeutics (IKT) United States $0.163B 0.00
Lyell Immunopharma (LYEL) United States $0.159B 0.00
Protara Therapeutics (TARA) United States $0.157B 0.00
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Larimar Therapeutics (LRMR) United States $0.138B 0.00
Nektar Therapeutics (NKTR) United States $0.127B 0.00
Journey Medical (DERM) United States $0.123B 0.00
Champions Oncology (CSBR) United States $0.120B 19.73
Enanta Pharmaceuticals (ENTA) United States $0.118B 0.00
Regulus Therapeutics (RGLS) United States $0.116B 0.00
Lexeo Therapeutics (LXEO) United States $0.115B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.115B 0.00
Telomir Pharmaceuticals (TELO) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
OptiNose (OPTN) United States $0.092B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Cardiol Therapeutics (CRDL) Canada $0.080B 0.00
Galectin Therapeutics (GALT) United States $0.077B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Cassava Sciences (SAVA) United States $0.072B 0.00
ESSA Pharma (EPIX) Canada $0.070B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.069B 0.00
Nutriband (NTRB) United States $0.068B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.065B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Pyxis Oncology (PYXS) United States $0.060B 0.00
Unicycive Therapeutics (UNCY) United States $0.060B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Context Therapeutics (CNTX) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
AleAnna (ANNA) United States $0.052B 0.00
Metagenomi (MGX) United States $0.051B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Dominari Holdings (DOMH) United States $0.044B 0.00
Iterum Therapeutics (ITRM) Ireland $0.043B 0.00
Prelude Therapeutics (PRLD) United States $0.042B 0.00
Century Therapeutics (IPSC) United States $0.041B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Surrozen (SRZN) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Tempest Therapeutics (TPST) United States $0.034B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
Karyopharm Therapeutics (KPTI) United States $0.031B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
DURECT (DRRX) United States $0.025B 0.00
VYNE Therapeutics (VYNE) United States $0.024B 0.00
Mural Oncology (MURA) Ireland $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Enlivex Therapeutics (ENLV) Israel $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
BioVie (BIVI) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 6.90
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 8.95
TherapeuticsMD (TXMD) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Cosmos Health (COSM) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
ProPhase Labs (PRPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 2.89
Relmada Therapeutics (RLMD) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Alaunos Therapeutics (TCRT) United States $0.002B 0.00
CERo Therapeutics Holdings (CERO) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
TransCode Therapeutics (RNAZ) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00